Simplex Trading
ANVS icon

Simplex Trading’s Annovis Bio ANVS Stock Holding History

Simplex Trading’s Portfolio ANVS Stock Details ANVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$281K Buy
125,800
+1,800
+1% +$4.94K ﹤0.01% 3896
2025
Q4 		$429K Buy
124,000
+77,800
+168% +$234K ﹤0.01% 3452
2025
Q3 		$95K Sell
46,200
-3,900
-8% -$9.75K ﹤0.01% 5794
2025
Q2 		$108K Buy
50,100
+40,400
+416% +$79.7K ﹤0.01% 5153
2025
Q1 		$14K Sell
9,700
-35,700
-79% -$109K ﹤0.01% 6824
2024
Q4 		$228K Buy
45,400
+37,600
+482% +$272K ﹤0.01% 4379
2024
Q3 		$62K Sell
7,800
-70,600
-90% -$662K ﹤0.01% 5693
2024
Q2 		$451K Sell
78,400
-83,200
-51% -$674K ﹤0.01% 3776
2024
Q1 		$1.92M Buy
161,600
+152,100
+1,601% +$1.66M ﹤0.01% 2439
2023
Q4 		$177K Buy
+9,500
New +$84.2K ﹤0.01% 4790

Other funds holding ANVS

Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
MFG
Merit Financial Group Alpharetta, Georgia $16.4B AUM 25.17% 1-Year Est. Return

Simplex Trading's ANVS Position: Q4 2025 in Review

Simplex Trading sold out of Annovis Bio (ANVS) in Q4 2025, closing a stake of 4,091 shares — an estimated $12.3K sold.

Simplex Trading first reported a position in ANVS in Q3 2024 and held it in 4 quarters. The position peaked at $69K in Q3 2024. 53 funds tracked by Wall St. Rank hold ANVS as of Q4 2025.

  • Simplex Trading reported no remaining Annovis Bio position as of Q4 2025 after selling out during the quarter.
  • Simplex Trading sold 4,091 Annovis Bio shares in Q4 2025, an estimated $12.3K.
  • Simplex Trading first reported a position in Annovis Bio in Q3 2024 and held it in 4 quarters.
  • Simplex Trading's Annovis Bio position peaked at $69K in Q3 2024.
  • 53 funds tracked by Wall St. Rank held Annovis Bio as of Q4 2025.

Based on Simplex Trading's 13F filing for Q4 2025, filed 11 Feb 2026.